+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Rx/Reimbursement Adult Incontinence in Sweden

  • PDF Icon

    Report

  • 18 Pages
  • March 2024
  • Region: Sweden
  • Euromonitor International
  • ID: 4517586
In 2023, current value sales of Rx/reimbursement adult incontinence rose substantially due to a spike in unit prices. Although Rx/reimbursement adult incontinence products are available free of charge through Sweden’s public healthcare system, volume growth has been sluggish since the outbreak of COVID-19. In 2023, significant unit price increases dampened demand pushing volume growth rates below 2022 levels as the inflation rate in the country rose.

The Rx/Reimbursement adult incontinence in Sweden report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2028 illustrate how the market is set to change.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the Rx/Reimbursement adult incontinence market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Table of Contents

RX/REIMBURSEMENT ADULT INCONTINENCE IN SWEDENKEY DATA FINDINGS
2023 DEVELOPMENTS
  • Inflation triggers surge in current value sales
  • Ageing population drives demand for Rx/reimbursement adult incontinence
  • COVID-19 pandemic has limited effect on demand patterns
PROSPECTS AND OPPORTUNITIES
  • Economic uncertainty encourages more incontinence sufferers towards Rx
  • Ageing of the Swedish population continues to drive category development while industry bodies work to reduce the stigma of incontinence
  • Rising costs of Rx/reimbursement adult incontinence provide impetus to alternatives, such as bladder training
CATEGORY DATA
  • Table 1 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2018-2023
  • Table 2 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2018-2023
  • Table 3 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2023-2028
  • Table 4 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2023-2028
TISSUE AND HYGIENE IN SWEDEN
EXECUTIVE SUMMARY
  • Tissue and hygiene in 2023: The big picture
  • 2023 key trends
  • Competitive landscape
  • Retailing developments
  • What next for tissue and hygiene?
MARKET INDICATORS
  • Table 5 Birth Rates 2018-2023
  • Table 6 Infant Population 2018-2023
  • Table 7 Female Population by Age 2018-2023
  • Table 8 Total Population by Age 2018-2023
  • Table 9 Households 2018-2023
  • Table 10 Forecast Infant Population 2023-2028
  • Table 11 Forecast Female Population by Age 2023-2028
  • Table 12 Forecast Total Population by Age 2023-2028
  • Table 13 Forecast Households 2023-2028
MARKET DATA
  • Table 14 Retail Sales of Tissue and Hygiene by Category: Value 2018-2023
  • Table 15 Retail Sales of Tissue and Hygiene by Category: % Value Growth 2018-2023
  • Table 16 NBO Company Shares of Retail Tissue and Hygiene: % Value 2019-2023
  • Table 17 LBN Brand Shares of Retail Tissue and Hygiene: % Value 2020-2023
  • Table 18 Penetration of Private Label in Retail Tissue and Hygiene by Category: % Value 2018-2023
  • Table 19 Distribution of Retail Tissue and Hygiene by Format: % Value 2018-2023
  • Table 20 Distribution of Retail Tissue and Hygiene by Format and Category: % Value 2023
  • Table 21 Forecast Retail Sales of Tissue and Hygiene by Category: Value 2023-2028
  • Table 22 Forecast Retail Sales of Tissue and Hygiene by Category: % Value Growth 2023-2028
DISCLAIMER
SOURCES
  • Summary 1 Research Sources